Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Feb;43(2):97-110.
doi: 10.1136/jmg.2005.030833. Epub 2005 May 6.

Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease

S A Abdalla  1 , M Letarte
Affiliations
Review

Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease

S A Abdalla et al. J Med Genet. 2006 Feb.

Abstract

Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterised by epistaxis, telangiectases, and multiorgan vascular dysplasia. The two major types of disease, HHT1 and HHT2, are caused by mutations in the ENG (endoglin) and ACVRL1 genes, respectively. The corresponding endoglin and ALK-1 proteins are specific endothelial receptors of the transforming growth factor beta superfamily essential for maintaining vascular integrity. Many mutations have been identified in ENG and ACVRL1 genes and support the haploinsufficiency model for HHT. Two more genes have recently been implicated in HHT: MADH4 mutated in a combined syndrome of juvenile polyposis and HHT (JPHT), and an unidentified HHT3 gene linked to chromosome 5. Current knowledge on the genetics of HHT is summarised, including the pathways that link the genes responsible for HHT and the potential mechanisms underlying the pathogenesis of the disease.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: none declared

References

    1. Guttmacher A E, Marchuk D A, White R I. Hereditary hemorrhagic telangiectasia. N Engl J Med 1995333918–924. - PubMed
    1. Dakeishi M, Shioya T, Wada Y, Shindo T, Otaka K, Manabe M, Nozaki J, Inoue S, Koizumi A. Genetic epidemiology of hereditary haemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat 200219140–148. - PubMed
    1. Kjeldsen A D, Vase P, Green A. Hereditary haemorrhagic telangiectasia: a population‐based study of prevalence and mortality in Danish patients. J Intern Med 199924531–39. - PubMed
    1. Plauchu H, Bideau A. Epidemiologie et constitution d'un registre de population a propos d'une concentration geographique d'une maladie hereditaire rare. Population 19844–5765–786.
    1. Bideau A, Plauchu H, Jacquard A, Robert J M, Desjardins B. Genetic aspects of Rendu‐Osler disease in Haut‐Jura: convergence of methodological approaches of historic demography and medical genetics. J Genet Hum 198028127–147. - PubMed

MeSH terms